As of May 31
| +0.04 / +1.05%|
The 5 analysts offering 12-month price forecasts for Ocuphire Pharma Inc have a median target of 20.00, with a high estimate of 24.00 and a low estimate of 17.00. The median estimate represents a +418.13% increase from the last price of 3.86.
The current consensus among 5 polled investment analysts is to Buy stock in Ocuphire Pharma Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.